Human p53 and Hdm2: Cloning and Construction of Expression Plasmid

REFERENCES

• Barak , Y. , T. Juven , et al. . 1993 . Mdm2 expression is induced by wild type p53 activity . EMBO J. 12 : 461 – 68 .
   PubMed Web of Science ®Google Scholar
• Ben David , Y. , V. R. Prideaux , et al. . 1988 . Inactivation of the p53 oncogene by internal deletion or retroviral integration in erytroleukemic cell lines induced by Friend leukemia virus . Oncogene 3 : 179 – 85 .
   PubMed Web of Science ®Google Scholar
• Boyd , S. D. , K. Y. Tsai , and T. Jacks . 2000 . An intact HDM2. RING-finger domain is required for nuclear exclusion of p53 . Nat. Cell Biol. 2 : 563 – 68 .
   PubMed Web of Science ®Google Scholar
• Carr , A. M. 2000 . Piecing together the p53 puzzle . Science 287 : 1765 – 66 .
   PubMed Web of Science ®Google Scholar
• Chene , P. , J. Fuchs , et al. . 2000 . A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines . J. Mol. Biol. 299 : 245 – 53 .
   PubMed Web of Science ®Google Scholar
• De Rozieres , S. , R. Maya , et al. . 2000 . The loss of mdm2 induces p53 mediated apoptosis . Oncogene 19 : 1691 – 97 .
   PubMed Web of Science ®Google Scholar
• Eymin , B. , S. Gazzeri , et al. . 2002 . Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors . Oncogene 21 : 2750 – 61 .
   PubMed Web of Science ®Google Scholar
• Fakharzadeh , S. S. , S. P. Trusko , and D. L. George . 1991 . Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line . EMBO J. 10 : 1565 – 69 .
   PubMed Web of Science ®Google Scholar
• Fang , S. , J. P. Jensen , et al. . 2000 . Ubiquitin protein ligase activity of Mdm2: Differential RING finger requirements for ubiquitination and proteasomal targeting of Mdm2 and p53 . J. Biol. Chem. 275 : 8945 – 51 .
   PubMed Web of Science ®Google Scholar
• Finlay , C. A. , P. W. Hinds , and A. J. Levine . 1989 . The p53 proto-oncogene can act as a suppressor of transformation . Cell 57 : 1083 – 93 .
   PubMed Web of Science ®Google Scholar
• Geyer , R. K. , Z. K. Yu , and C. G. Maki . 2000 . The Mdm2 ring-finger domain is required to promote p53 nuclear export . Nat. Cell Biol. 2 : 569 – 73 .
   PubMed Web of Science ®Google Scholar
• Gu , J. , N. Nie , et al. . 2001 . Identification of p53 sequence elements that are required for Mdm2-mediated nuclear export . Mol. Cell Biol. 21 : 8533 – 46 .
   PubMedGoogle Scholar
• Harlow , E. D. , N. M. Williamson , et al.. 1985. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell Biol. 5: 1601–10.
   PubMed Web of Science ®Google Scholar
• Haupt , Y. , R. Maya , et al. . 1997 . Mdm2 promotes the rapid degradation of p53 . Nature 387 : 296 – 99 .
   PubMed Web of Science ®Google Scholar
• Hinds , P. , C. Finlay , and A. J. Levine . 1989 . Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation . J. Virol. 63 : 739 – 46 .
   PubMed Web of Science ®Google Scholar
• Hollstein , M. , D. Sidransky , et al. . 1991 . p53 mutations in human cancers . Science 253 : 49 – 53 .
   PubMed Web of Science ®Google Scholar
• Honda , R. , H. Tanaka , and H. Yasuda . 1997 . Oncoprotein Mdm2 is a ubiquitin ligase E3 for tumor suppressor p53 . FEBS Lett. 420 : 25 – 27 .
   PubMed Web of Science ®Google Scholar
• Jones , S. N. , A. E. Roe , et al. . 1995 . Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 . Nature 378 : 206 – 08 .
   PubMed Web of Science ®Google Scholar
• Juven-Gershon , T. , O. Shifman , et al. . 1998 . The Mdm2 oncoprotein interacts with the cell fate regulator Numb . Mol. Cell Biol. 18 : 3974 – 82 .
   PubMedGoogle Scholar
• Kawasaki , E. S. , and A. M. Wang . 1989 . Detection of gene expression . In PCR Technology , ed. H. A. Erlich , 89 – 97 . New York : Stockton .
   Google Scholar
• Kubbutat , M. H. G. , S. N. Jones , and K. H. Vousden . 1997 . Regulation of p53 stability by Mdm2 . Nature 387 : 299 – 03 .
   PubMed Web of Science ®Google Scholar
• Laemmli , U. K. 1970 . Cleavage of structural protein during the assembly of the head of bacteriophage T7 . Nature 227 : 680 – 85 .
   PubMed Web of Science ®Google Scholar
• Lane , D. P. , and L. V. Crawford . 1979 . T antigen is bound to a host protein in SV40 transformed cells . Nature 278 : 261 – 63 .
   PubMed Web of Science ®Google Scholar
• Lane , D. P. , and P. A. Hall . 1997 . Mdm2-arbiter of p53's destruction . Trends Biochem. Sci. 22 : 372 – 74 .
   PubMed Web of Science ®Google Scholar
• Leite , K. R. , M. F. Franco , et al. . 2001 . Abnormal expression of Mdm2 in prostate carcinoma . Mod. Pathol. 14 : 428 – 36 .
   PubMed Web of Science ®Google Scholar
• Levellard , T. , and B. Wasylyk . 1997 . The Mdm2 C-terminal region binds to TAFII 250 and is required for Mdm2 regulation of cyclin A promoter . J. Biol. Chem. 272 : 30651 – 61 .
   PubMedGoogle Scholar
• Linzer , D. I. , and A. J. Levine . 1979 . Characterization of a 54 K Dalton cellular SV40 tumor antigen present in SV40 – transformed cells and uninfected embryonal carcinoma cells . Cell 17 : 43 – 52 .
   PubMed Web of Science ®Google Scholar
• Lohrum , M. A. E. , D. B. Woods , et al. . 2001 . C-terminal ubiquitination of p53 contributes to nuclear export . Mol. Cell. Biol. 21 : 8521 – 32 .
   PubMedGoogle Scholar
• Lowe , S. W. , and A. W. Lin . 2000 . Apoptosis in cancer . Carcinogenesis 21 : 485 – 95 .
   PubMed Web of Science ®Google Scholar
• Lowry , O. H. , N. J. Rosebrough , et al. . 1951 . Protein measurement with the folin phenol reagent . J. Biol. Chem. 193 : 265 – 75 .
   PubMed Web of Science ®Google Scholar
• Malkin , D. , F. P. Li , et al. . 1990 . Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms . Science 250 : 1233 – 38 .
   PubMed Web of Science ®Google Scholar
• Meek , D. W. 1999 . Mechanism of switching on p53: A role for covalent modification? . Oncogene 18 : 7666 – 75 .
   PubMed Web of Science ®Google Scholar
• Meltzer , P. S. , S. A. Jankowski , et al. . 1991 . Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors . Cell Growth Differ. 2 : 495 – 501 .
   PubMedGoogle Scholar
• Momand , J. , G. P. Zambetti , et al. . 1992 . The Mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 – mediated transactivation . Cell 69 : 1237 – 45 .
   PubMed Web of Science ®Google Scholar
• Momand , J. , H. H. Wu , and G. Dasgupta . 2000 . Mdm2 – master regulator of the p53 tumor suppressor protein . Gene 242 : 15 – 29 .
   PubMed Web of Science ®Google Scholar
• Montes de Oca Luna , R. , D. S. Wagner , and G. Lozano . 1995 . Rescue of early embryonic lethality in Mdm2 – deficient mice by deletion of p53 . Nature 378 : 203 – 06 .
   PubMed Web of Science ®Google Scholar
• Mowat , M. , A. Cheng , et al.. 1985. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314: 633–36.
   PubMed Web of Science ®Google Scholar
• Oliner , J. D. , K. W. Kinzler , et al. . 1992 . Amplification of a gene encoding a p53 - associated protein in human sarcomas . Nature 358 : 80 – 83 .
   PubMed Web of Science ®Google Scholar
• Oliner , J. D. , J. A. Pietenpol , et al. . 1993 . Oncoprotein Mdm2 conceals the activation domain of tumor suppressor p53 . Nature 362 : 857 – 60 .
   PubMed Web of Science ®Google Scholar
• Polsky , D. , B. C. Bastian , et al. . 2001 . Hdm2 protein overexpression, but not amplification, is related to tumorigenesis of cutaneous melanoma . Cancer Res. 61 : 7642 – 46 .
   PubMed Web of Science ®Google Scholar
• Ryan , K. M. , A. C. Phillips , and K. H. Vousden . 2001 . Regulation and function of the p53 tumor suppressor protein . Curr. Biol. 13 : 332 – 37 .
   Google Scholar
• Saiki , R. K. , S. Scharf , et al. . 1985 . Amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia . Science 230 : 1350 – 54 .
   PubMed Web of Science ®Google Scholar
• Sambrook , J. , E. F. Fritsch , and T. Maniatis . 1989 . Extraction, purification and analysis of messenger RNA from eukaryotic cells . In Molecular Cloning. A Laboratory Manual, , 2nd ed. , 7.28 – 7.52 . Cold Spring Harbor , NY : Cold Spring Harbor Laboratory Press .
   Google Scholar
• Sarnow , P. , Y. S. Ho , et al. . 1982 . Adenovirus E1b-58 KD tumor antigen and SV 40 large tumor antigen are physically associated with the same 54 KD cellular protein in transformed cells . Cell 28 : 387 – 94 .
   PubMed Web of Science ®Google Scholar
• Sherr , C. J. , and J. D. Weber . 2000 . The ARF/p53 pathway . Curr. Opin. Genet. Dev. 10 : 94 – 99 .
   PubMed Web of Science ®Google Scholar
• Soussi , T. , C. Caron de Fromentel , et al. . 1987 . Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murin p53 . Oncogene 1 : 71 – 78 .
   PubMed Web of Science ®Google Scholar
• Srivastava , S. , Z. Zou , et al. . 1990 . Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome . Nature 348 : 747 – 49 .
   PubMed Web of Science ®Google Scholar
• Sturzbecher , H. W. , P. Chumakov , et al. . 1987 . Mutant p53 proteins bind hsp 72/73 cellular heart shock-related proteins in SV40–transformed monkey cells . Oncogene 1 : 201 – 11 .
   PubMed Web of Science ®Google Scholar
• Toogood , P. L. 2002 . Inhibition of protein–protein association by small molecules: Approaches and progress . J. Med. Chem. 45 : 1543 – 58 .
   PubMed Web of Science ®Google Scholar
• Vogelstein , B. 1990 . A deadly inheritance . Nature 348 : 681 – 82 .
   PubMed Web of Science ®Google Scholar
• Vousden , K. H. 2000 . p53: Death star . Cell 101 : 691 – 94 .
   Google Scholar
• Vousden , K. H. , and X. Lu . 2002 . Live or let die: The cell's response to p53 . Nat. Rev. Cancer 2 : 594 – 04 .
   PubMed Web of Science ®Google Scholar
• Wadgaonkar , R. , and T. Collins . 1999 . Murine double minute (Mdm2) blocks p53–coactivator interaction, a new mechanisms for inhibition of p53–dependent gene expression . J. Biol. Chem. 274 : 13760 – 67 .
   PubMedGoogle Scholar
• Wang , H. , X. Zeng , et al. . 1999 . Mdm2 oncogene as a target for cancer therapy: An antisense approach . Int. J. Oncol. 15 : 653 – 60 .
   PubMed Web of Science ®Google Scholar
• Werness , B. A. , A. J. Levine , and P. M. Howley . 1990 . Association of human papillomavirus types 16 and 18 E6 proteins with p53 . Science 248 : 76 – 79 .
   PubMed Web of Science ®Google Scholar
• Wu , X. W. , J. H. Bayle , et al. . 1993 . The p53 mdm-2 autoregulatory feedback loop . Genes Dev. 7 : 1126 – 32 .
   PubMed Web of Science ®Google Scholar